Microglial phagocytosis of neurons in neurodegeneration, and its regulation - PubMed (original) (raw)

Review

. 2021 Aug;158(3):621-639.

doi: 10.1111/jnc.15327. Epub 2021 Mar 17.

Affiliations

Free article

Review

Microglial phagocytosis of neurons in neurodegeneration, and its regulation

Claire A Butler et al. J Neurochem. 2021 Aug.

Free article

Abstract

There is growing evidence that excessive microglial phagocytosis of neurons and synapses contributes to multiple brain pathologies. RNA-seq and genome-wide association (GWAS) studies have linked multiple phagocytic genes to neurodegenerative diseases, and knock-out of phagocytic genes has been found to protect against neurodegeneration in animal models, suggesting that excessive microglial phagocytosis contributes to neurodegeneration. Here, we review recent evidence that microglial phagocytosis of live neurons and synapses causes neurodegeneration in animal models of Alzheimer's disease and other tauopathies, Parkinson's disease, frontotemporal dementias, multiple sclerosis, retinal degeneration and neurodegeneration induced by ischaemia, infection or ageing. We also review factors regulating microglial phagocytosis of neurons, including: nucleotides, frackalkine, phosphatidylserine, calreticulin, UDP, CD47, sialylation, complement, galectin-3, Apolipoprotein E, phagocytic receptors, Siglec receptors, cytokines, microglial epigenetics and expression profile. Some of these factors may be potential treatment targets to prevent neurodegeneration mediated by excessive microglial phagocytosis of live neurons and synapses.

Keywords: Alzheimer's disease; Parkinson's disease; ageing; microglia; neurodegeneration; neuroinflammation; phagocytosis.

© 2021 International Society for Neurochemistry.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ahmad, S., Kindelin, A., Khan, S., Ahmed, M., Hoda, M., Bhatia, K., & Ducruet, A. (2019). C3a receptor inhibition protects brain endothelial cells against oxygen-glucose deprivation/reperfusion. Experimental Neurobiology, 28(2), 216-228. https://doi.org/10.5607/en.2019.28.2.216
    1. Alawieh, A., Langley, E., Feng, W., Spiotta, A., & Tomlinson, S. (2020). Complement-dependent synaptic uptake and cognitive decline after stroke and reperfusion therapy. Journal of Neuroscience, 40(20), 4042-4058. https://doi.org/10.1523/JNEUROSCI.2462-19.2020
    1. Alawieh, A., Langley, E., Weber, S., Adkins, D., & Tomlinson, S. (2018). Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury. Journal of Neuroscience, 38(10), 2519-2532. https://doi.org/10.1523/JNEUROSCI.2197-17.2018
    1. Al-Dalahmah, O., Thakur, K., Nordvig, A., Prust, M., Roth, W., Lignelli, A., Uhlemann, A., Miller, E., Kunnath-Velayudhan, S., Del Portillo, A., Liu, Y., Hargus, G., Teich, A., Hickman, R., Tanji, K., Goldman, J., Faust, P., & Canoll, P. (2020). Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathologica Communications, 8(1), 147. https://doi.org/10.1186/s40478-020-01024-2
    1. Allendorf, D., Franssen, E., & Brown, G. (2020). Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll-like Receptor 4. Journal of Neurochemistry, 155(4), 403-416. https://doi.org/10.1111/jnc.15024

Publication types

MeSH terms

LinkOut - more resources